Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiolitis obliterans syndrome: pathogenesis and management.

Ramsey R Hachem1, Elbert P Trulock

  • 1Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. rhachem@im.wustl.edu

Seminars in Thoracic and Cardiovascular Surgery
|January 7, 2005
PubMed
Summary

Bronchiolitis obliterans syndrome (BOS) limits long-term lung transplant success. While immune injury is a known cause, nonimmune factors like gastroesophageal reflux are emerging as significant contributors to this major complication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

A single-center experience of 2000 adult lung transplants.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Trends in primary graft dysfunction and early mortality following lung transplantation: A single center experience.

JHLT open·2026
Same author

Venous Thromboembolism in Brain-Dead Organ Donors: A Prospective Study of Prevalence, Management, and Impact on Organ Utilization and Recipient Outcomes.

Clinical transplantation·2025
Same author

The NHLBI lung transplant consortium 2025 steering committee report: Strategies to maximize the use of the consortium for advancing lung transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

Atg16l1 promotes lung transplant tolerance by regulating glycolysis in macrophages.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Cardiovascular and Respiratory System Science
  • Transplantation Immunology

Background:

  • Lung transplantation is a vital treatment for end-stage lung disease.
  • Bronchiolitis obliterans syndrome (BOS) significantly limits long-term transplant outcomes.
  • BOS is the primary cause of late morbidity and mortality post-transplant.

Purpose of the Study:

  • To review the established and emerging causes of bronchiolitis obliterans syndrome (BOS).
  • To discuss the implications of both immune and nonimmune mechanisms in BOS development.
  • To highlight the challenges in managing BOS after lung transplantation.

Main Methods:

  • Literature review of studies on lung transplantation and BOS.
  • Analysis of immune-mediated injury as a cause of chronic rejection.

Related Experiment Videos

  • Investigation into nonimmune factors, including gastroesophageal reflux, implicated in BOS.

    • Main Results:

    • Immune-mediated injury is the primary recognized cause of BOS, often termed chronic rejection.
    • Nonimmune mechanisms, such as gastroesophageal reflux, are increasingly identified as contributing factors.
    • Current treatment options for BOS have yielded disappointing results.

    Conclusions:

    • BOS remains the leading cause of late graft failure and mortality after lung transplantation.
    • Understanding both immune and nonimmune pathways is crucial for effective BOS management.
    • Further research is needed to develop improved therapeutic strategies for BOS.